| Volume: | 4,449,339 |
|---|---|
| Day's Low: | $54.41 |
| 52-wk Low: | $45.46 |
| Previous Close: | $54.33 |
| Dividend: | $0.29 |
| Market Cap: | 32,952,400 |
| Avg Volume: | 4,319,000 |
|---|---|
| Day's High: | $55.20 |
| 52-wk High: | $60.99 |
| Open Price: | $54.98 |
| Yield: | 1.90% |
| P/E (Forward): | 14.38 |
| 8:34 AM | 11/20/2009 | EU Panel: Affirm Benefits Of Celvapan, Focetria, Pandemrix |
| 6:36 PM | 10/29/2009 | Baxter: Received Subpoena Regarding 'Colleague' Pumps |
| 12:21 PM | 10/29/2009 | UK Government: New Cases Of Swine Flu Still Rising |
| 3:28 PM | 10/15/2009 | US EARNINGS WRAP: Citigroup, Goldman Fall Despite Profit |
| 12:47 PM | 10/15/2009 | UK Swine Flu Cases Rise, Vaccines Available From Next Week |
| 11:45 AM | 10/15/2009 | 2nd UPDATE: Baxter 3Q Net Rises 12%; Sales Hit By Currency |
| 9:05 AM | 10/15/2009 | UPDATE: Baxter 3Q Net Rises 12%; Sales Hit By Currency |
| 11/14/2009 | A Wynn Resorts Special |
| 11/10/2009 | Time to Order the Top-Shelf Stuff |
| 11/2/2009 | Jittery Companies Stash Cash |
| 11/2/2009 | Turnaround Letter not for faint of heart |
| 10/22/2009 | Baxter's key is versatility |
| 10/16/2009 | Oil Boosts Chevron; Goldman Falls 1.9% |
| 10/15/2009 | Updates, advisories and surprises |
| Most Recent Quarter ($) | Same Quarter Last Year ($) | % Change | |
| EPS, Pro Forma | 0.98 | 0.88 | 11.36 |
| EPS, GAAP | 0.87 | 0.74 | 17.57 |
| Consensus Estimate | 0.96 | 0.82 | 17.07 |
| Trailing 12 Months | Year-Earlier Period | % Change | |
| EPS, Pro Forma | 3.68 | 3.38 | 8.88 |
| EPS, GAAP | 3.56 | 3.00 | 18.67 |
| Consensus Estimate | 3.60 | NA | NA |
| BAX | Industry Average | |
| P/E (TTM) | 15.35 | 50.80 |
| P/E (Forward) | 14.38 | 11.40 |
| PEG Ratio | 1.25 | 0.67 |
| Price/Sales | 2.74 | 2.56 |
| Beta | 0.44 | 0.40 |